MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application
/PRNewswire/ - MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) is pleased to announce it has completed the National Phase filing of...
British Columbia Lyle Oberg Financial Ltd World Health Organization Canadian Securities Exchange National Phase
Source: prnewswire.com